J. Jason Lundy, PhD is a measurement scientist specializing in the development and analysis of clinical outcome assessments. Jason has worked on numerous PRO instrument qualification projects in collaboration with FDA and industry colleagues. Over the past ten years, he has written extensively about measurement equivalence and best practices for the electronic implementation of PRO measures in clinical studies. Dr. Lundy has developed PRO measures in a variety of therapeutic areas, and he has helped to support the use of PRO instruments as endpoints in discussions with regulatory agencies. Dr. Lundy earned his PhD in Pharmaceutical Economics, Policy, and Outcomes Research from the University of Arizona.